Your browser doesn't support javascript.
loading
Lipidomics study of Liujunzi decoction in hyperlipidemia rats with spleen deficiency based on UPLC-Q-TOF/MS.
Sun, Shuang; Guo, Hongli; Shang, Eryu; Guo, Qiaoxin; Ju, Aixia; Li, Yalun; Feng, Yawen; Guo, Yuyan; Yang, Dayu; Lü, Shaowa.
Affiliation
  • Sun S; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Guo H; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Shang E; Fire Control Room, Heilongjiang Forest Protection Institute, Harbin, China.
  • Guo Q; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Ju A; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Li Y; University of Wisconsin Madison, Madison, WI, 53715, USA.
  • Feng Y; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Guo Y; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Yang D; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
  • Lü S; College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Heliyon ; 10(11): e31710, 2024 Jun 15.
Article in En | MEDLINE | ID: mdl-38882295
ABSTRACT
Hyperlipidemia refers to the abnormal levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL-C) and high-density lipoprotein (HDL-C) in peripheral blood circulation. It is a predominant risk factor underlying cardiovascular and cerebrovascular diseases, including coronary heart disease and atherosclerosis. Furthermore, it is also one of the most prevalent chronic diseases globally. Liujunzi Decoction is the basic prescription for the treatment of spleen and stomach diseases. It can tonify the spleen and qi, remove dampness, and reduce turbidity. Moreover, it is also clinically used for the treatment of spleen deficiency hyperlipidemia. However, its metabolites and therapeutic effect on spleen deficiency hyperlipidemia have not been comprehensively determined in vitro and in vivo. This study established a rat model of spleen deficiency hyperlipidemia by inducing starvation and satiety disorders, exhaustion swimming, and intragastric administration of the fat emulsion. To identify related metabolite changes and serum lipid composition, UPLC-Q-TOF-MS, PCA, and OPLS-DA lipidological methods were performed. The results demonstrated significant changes in rat's signs during the modeling process, which were consistent with the criteria for the syndrome differentiation of spleen deficiency in traditional Chinese medicine. Furthermore, this study identified 100 potential biomarkers in rat serum, of which 52 were associated with lipid synthesis, such as LPC, PC, PI, PE, PA, Cer, SM, etc. The pathways involved were glycerol phospholipid, sphingomyelin, and glycerol ester metabolisms. After the Liujunzi decoction intervention, 56 potential biomarkers were observed in the high-dose group, alleviating the metabolic spectrum imbalance by reducing metabolite levels. In addition, metabolic pathway disturbances were markedly improved. This study provides references for future studies on Liujunzi decoction and furnishes essential data for assessing the relationships between chemical constituents and pharmacological activities of Liujunzi decoction.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2024 Document type: Article Affiliation country: